Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotechnology Value Fund, L.P. -- Ignore unavailable to you. Want to Upgrade?

To: sim1 who wrote (4592)	2/23/2006 1:22:21 PM
From: keokalani'nui	Read Replies (2) \| Respond to of 4974

>>The situation for emerging companies looking to list has been aggravated by the Sarbanes-Oxley Act, which requires executives and auditors to vouch for the adequacy and effectiveness of internal controls each year, he said.<< Really. How hard could this possibly be for a development stage biotech? Two check signers, two accountants, and you're done.

To: sim1 who wrote (4592)	3/10/2006 1:49:25 PM
From: nigel bates	Read Replies (1) \| Respond to of 4974

Many European companies have scrapped U.S. listings.. LONDON (AFP) - The London Stock Exchange said it had received a preliminary cash bid from the Nasdaq Stock Exchange in New York but added that the offer worth 950 pence per share "substantially undervalues" the company. The proposal values the LSE at about 2.42 billion pounds ( 4.18 billion dollars). "The board of the London Stock Exchange (LSE: LSE.L - news) announces that it has received a pre-conditional proposal from the Nasdaq Stock Market , with a view to Nasdaq (NASDAQ: news) making an offer to acquire the company for 950p per share in cash," a statement said. "The Board of London Stock Exchange firmly believes that the proposal, which represents only an eight percent premium to the current market price, substantially undervalues the company, its unique position and the very significant synergies that would be achievable from the combination of London Stock Exchange with any major exchange group," the statement added...